Advances in Healthcare, Cancer Treatment, Industrial Wastewater Management, and Transistors

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Inside R&D TOE depicts innovations in healthcare, industrial wastewater treatment, and transistors. The TOE also emphasizes on developments in the fields of cancer treatment and bispecific antibodies.Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas. We provide intelligence and insights on innovations spanning a wide variety of industry areas, including automation, electronics, sensors, information and communication technologies, manufacturing, health, wellness, medical devices, pharma, biotechnology, materials, coatings, renewable fuels, automotive, power systems, sustainable energy solutions and i

Table of Contents

Advances in Healthcare, Cancer Treatment, Industrial Wastewater Management, and TransistorsInnovations in Healthcare, Cancer Treatment, Industrial Wastewater Management and Transistors Key Cancer Enzyme’s Structure DefinedNovel Bispecific Full Length Human Antibodies for Cancer TreatmentRe-emergence of Research across Bispecific AntibodiesNovel Photocatalytic Composite Material for Removal of Synthetic Dye Pollutants using SunlightCarbon-based Transistors for Next-gen Computers

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.